IIPLA News
Wednesday, May 27, 2026

CanVeer Biopharma Advances Global Patent Protection with PCT Filing for AlveoShield™ in Respiratory Disease Treatment

International patent application strengthens CanVeer’s intellectual property portfolio for novel therapies targeting chronic lung conditions including bronchopulmonary dysplasia

IIPLA News Deskanonymous access0 articles left this week
CanVeer Biopharma Advances Global Patent Protection with PCT Filing for AlveoShield™ in Respiratory Disease Treatment
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

CanVeer Biopharma Inc. has filed an international Patent Cooperation Treaty (PCT) application for its lead investigational drug candidate AlveoShield™, marking a strategic step in securing global intellectual property rights. The filing supports CanVeer’s development of disease-modifying therapies for severe respirato…
Share This Article
Ready-to-post copy includes the article link.

CanVeer Biopharma Advances Global Patent Protection with PCT Filing for AlveoShield™ in Respiratory Disease Treatment CanVeer Biopharma Inc. has filed an international Patent Cooperation Treaty (PCT) application for its lead investigational drug candidate AlveoShield™, marking a strategic step in securing global intellectual property r... Read the full IIPLA article: https://iipla.org/news/canveer-biopharma-advances-global-patent-protection-with-pct-filing-for-alveoshield-in-respiratory-disease-treatment

Related Coverage

Continue in the newsroom

Back to newsroom